Chinese whistleblower tags Shanghai Pharma with bribery allegations

Shanghai Pharma, one of China's largest drugmakers, said it is investigating whistleblower claims that it bribed hospital staffers to amp up sales of its drugs. According to allegations reported in the Chinese media, a Shanghai subsidiary spent 766,500 yuan ($126,200) on bribes between January and June of this year. A pharma bribery scandal erupted in July, when the Chinese government detained local GlaxoSmithKline ($GSK) managers in connection with corruption allegations. Report